Characterization, in Vivo Evaluation, and Molecular Modeling of Different Propofol-Cyclodextrin Complexes To Assess Their Drug Delivery Potential at the Blood-Brain Barrier Level
暂无分享,去创建一个
Serdar Durdagi | Horacio Emilio Pérez Sánchez | Ramin Ekhteiari Salmas | Sergey Shityakov | Ellaine Salvador | Katalin Pápai | Maria Josefa Yáñez-Gascón | István Puskás | Norbert Roewer | Carola Förster | Jens-Albert Broscheit | R. E. Salmas | S. Durdağı | N. Roewer | M. Yáñez-Gascón | C. Förster | S. Shityakov | J. Broscheit | Ellaine Salvador | I. Puskás | K. Pápai | Horacio Emilio Pérez Sánchez | Katalin Pápai
[1] V. Stella,et al. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. , 1996, Journal of pharmaceutical sciences.
[2] Tamás Sohajda,et al. Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin , 2014, Molecules.
[3] N. Bodor,et al. Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. , 1988, Journal of pharmaceutical sciences.
[4] H. Pajouhesh,et al. Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.
[5] E. Coutinho,et al. Sulfobutyl Ether7 β-Cyclodextrin (SBE7 β-CD) Carbamazepine Complex: Preparation, Characterization, Molecular Modeling, and Evaluation of In Vivo Anti-epileptic Activity , 2011, AAPS PharmSciTech.
[6] A. Seelig,et al. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.
[7] N. Roewer,et al. Sevoflurane-Sulfobutylether-β-Cyclodextrin Complex: Preparation, Characterization, Cellular Toxicity, Molecular Modeling and Blood-Brain Barrier Transport Studies , 2015, Molecules.
[8] Holger Gohlke,et al. Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf , 2004, J. Comput. Chem..
[9] G. Trapani,et al. Inclusion Complexation of Propofol with 2-Hydroxypropyl-β- cyclodextrin. Physicochemical, Nuclear Magnetic Resonance Spectroscopic Studies, and Anesthetic Properties in Rat , 1998 .
[10] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[11] David Baker,et al. Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.
[12] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[13] K. Uekama,et al. Cyclodextrins in drug carrier systems. , 1987, Critical reviews in therapeutic drug carrier systems.
[14] P A Kollman,et al. Molecular recognition by beta-cyclodextrin derivatives: FEP vs MM/PBSA study. , 2001, Combinatorial chemistry & high throughput screening.
[15] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[16] J. Szejtli. Helical and Cyclic Structures in Starch Chemistry , 1991 .
[17] T. Egan,et al. Propofol in a Modified Cyclodextrin Formulation: First Human Study of Dose–Response with Emphasis on Injection Pain , 2011, Anesthesia and analgesia.
[18] J. Pople,et al. Self‐Consistent Molecular‐Orbital Methods. IX. An Extended Gaussian‐Type Basis for Molecular‐Orbital Studies of Organic Molecules , 1971 .
[19] B. Mikami,et al. Crystal Structure of Recombinant Soybean β-Amylase Complexed with β-Cyclodextrin* , 1998, The Journal of Biological Chemistry.
[20] B. Damle,et al. Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD). , 2010, Journal of pharmaceutical sciences.
[21] C. Goodchild,et al. Alphaxalone Reformulated: A Water-Soluble Intravenous Anesthetic Preparation in Sulfobutyl-Ether-&bgr;-Cyclodextrin , 2015, Anesthesia and analgesia.
[22] R. Farinotti,et al. Pharmacokinetics and Protein Binding of Propofol in Patients with Cirrhosis , 1988, Anesthesiology.
[23] A. Juluri,et al. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[24] P. Kollman,et al. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .
[25] L. Fenart,et al. Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood–brain barrier , 2006 .
[26] Ajay,et al. Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.
[27] H. Shang,et al. Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres , 2016, Drug design, development and therapy.
[28] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[29] S. Kampe,et al. Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil * , 2003, Anaesthesia.
[30] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[31] Talmage D Egan,et al. The Pharmacokinetics and Pharmacodynamics of Propofol in a Modified Cyclodextrin Formulation (Captisol®) Versus Propofol in a Lipid Formulation (Diprivan®): An Electroencephalographic and Hemodynamic Study in a Porcine Model , 2003, Anesthesia and analgesia.
[32] T. Duke,et al. A new intravenous anesthetic agent: propofol. , 1995, The Canadian veterinary journal = La revue veterinaire canadienne.
[33] P. Sebel,et al. Propofol: A New Intravenous Anesthetic , 1989, Anesthesiology.
[34] K. Ashok,et al. Cyclodextrins as Drug Carrier Molecule: A Review , 2008 .
[35] M. Másson,et al. Cyclodextrins in topical drug formulations: theory and practice. , 2001, International journal of pharmaceutics.
[36] M. Brewster,et al. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.
[37] Yun Tang,et al. In SilicoPrediction of Blood–Brain Partitioning Using a Chemometric Method Called Genetic Algorithm Based Variable Selection , 2008 .
[38] Anton J. Hopfinger,et al. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..